Rosalia Viterbo MD
Minimally Invasive Surgery, Infections & Inflammation, Surgical Oncology
Urologic Oncologist, Professor at Fox Chase Cancer Center/ TUH
Join to View Full Profile
333 Cottman AvenuePhiladelphia, PA 19111
Phone+1 215-728-6900
Dr. Viterbo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rosalia Viterbo is a Philadelphia-based urologist specializing in minimally invasive surgery, infections and inflammation, and surgical oncology. She completed her medical education at the Jacobs School of Medicine and Biomedical Sciences and pursued residency training in surgery and urology at Temple University Hospital. Following this, she undertook a fellowship in complex general and urologic surgical oncology at the City of Hope National Medical Center. Dr. Viterbo is a urologic oncologist and a Professor at Temple University Health System, focusing on prostate cancer, kidney cancer, bladder, testicular oncology, minimally invasive/robotic surgery. Her research has been published in leading journals, contributing notably to the field. Furthermore, she has been recognized with several CMS Meaningful Use certifications and is a Fellow of the American College of Surgeons.
Education & Training
City of Hope National Medical CenterFellowship, Complex General Surgical Oncology, 2006 - 2007
Temple University HospitalResidency, Urology, 2002 - 2006- Temple University HospitalResidency, Surgery, 2000 - 2002
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2000
Certifications & Licensure
CA State Medical License 2006 - Present
NJ State Medical License 2023 - 2027
PA State Medical License 2001 - 2026
American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Publications & Presentations
PubMed
- 18 citationsPhase II Trial of Risk-Enabled Therapy After Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer (RETAIN 1).Daniel M Geynisman, Philip H Abbosh, Eric Ross, Matthew R Zibelman, Pooja Ghatalia
Journal of Clinical Oncology. 2025-03-20 - A Randomized, Controlled Trial Evaluating Perioperative Risk-stratification and Risk-based, Protocol-driven Management After Elective Major Cancer Surgery.Nestor F Esnaola, Raju Chelluri, Jason Castellanos, Ariella Altman, David Y T Chen
Annals of Surgery. 2025-03-01 - 5 citationsSymptomatic and functional recovery after transurethral resection of bladder tumor: Data from ecological momentary symptom assessment.Marshall Strother, Ryan Barlotta, Robert Uzzo, Evan Bloom, Seyed B Jazayeri
Urologic Oncology. 2024-04-01
Journal Articles
- Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid FeaturesRichard E Greenberg, Rosalia Viterbo, Timothy Ito, Marc C Smaldone, Joseph R Testa, Philip H Abbosh, Robert G Uzzo, Alexander Kutikov, The Journal of Urology
Press Mentions
Better Robotic RP Skills Linked to Better ResultsJuly 14th, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
